
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.550 | 3.550 | 0.000 |
Shares | 96.450 | 96.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.758 | 35.834 |
Price to Book | 3.522 | 4.936 |
Price to Sales | 3.891 | 5.149 |
Price to Cash Flow | 16.904 | 24.369 |
Dividend Yield | 0.641 | 0.628 |
5 Years Earnings Growth | 10.744 | 13.691 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.080 | 96.429 |
Basic Materials | 2.800 | 4.570 |
Financial Services | 1.120 | 3.247 |
Number of long holdings: 37
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12.23 | 1,625.90 | +1.09% | |
Divi's Labs | INE361B01024 | 8.95 | 5,969.00 | -0.38% | |
Dr Reddy’s Laboratories | INE089A01031 | 8.92 | 1,218.70 | -0.07% | |
Cipla | INE059A01026 | 7.75 | 1,520.00 | +1.01% | |
Aurobindo Pharma | INE406A01037 | 6.06 | 1,055.80 | +0.28% | |
Biocon | INE376G01013 | 5.02 | 354.35 | +3.58% | |
Mankind Pharma | INE634S01028 | 4.20 | 2,432.70 | -0.15% | |
Alkem Laboratories Ltd | INE540L01014 | 4.01 | 5,165.00 | +6.62% | |
Lupin | INE326A01037 | 3.79 | 1,942.00 | -0.14% | |
Gland | INE068V01023 | 3.57 | 1,935.30 | -0.05% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 723.36B | 5.79 | 19.04 | 13.76 | ||
ICICI Focused Bluechip Eq RetailDiv | 723.36B | 5.02 | 18.18 | 12.96 | ||
ICICI Prud Focused Bluechip Div | 723.36B | 5.90 | 19.46 | 14.25 | ||
ICICI Prud Focused Bluechip Gr | 723.36B | 6.14 | 19.73 | 14.61 | ||
ICICI Prudential Balanced Adv Gr | 652.98B | 6.49 | 13.29 | 10.78 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review